共 25 条
Efficacy and safety of abciximab on acute myocardial infarction treated with percutaneous coronary interventions:: A meta-analysis of randomized, controlled trials
被引:27
作者:

Araújo, JODF
论文数: 0 引用数: 0
h-index: 0
机构: Hosp Venerovel Ordem Terceira Penitencia VOTCOR, BR-20530001 Rio De Janeiro, Brazil

Veloso, HH
论文数: 0 引用数: 0
h-index: 0
机构: Hosp Venerovel Ordem Terceira Penitencia VOTCOR, BR-20530001 Rio De Janeiro, Brazil

De Paiva, JMB
论文数: 0 引用数: 0
h-index: 0
机构: Hosp Venerovel Ordem Terceira Penitencia VOTCOR, BR-20530001 Rio De Janeiro, Brazil

Wafae, M
论文数: 0 引用数: 0
h-index: 0
机构: Hosp Venerovel Ordem Terceira Penitencia VOTCOR, BR-20530001 Rio De Janeiro, Brazil

De Paola, AAV
论文数: 0 引用数: 0
h-index: 0
机构: Hosp Venerovel Ordem Terceira Penitencia VOTCOR, BR-20530001 Rio De Janeiro, Brazil
机构:
[1] Hosp Venerovel Ordem Terceira Penitencia VOTCOR, BR-20530001 Rio De Janeiro, Brazil
[2] Univ Fed Sao Paulo, Escola Paulista Med, Dept Cardiol, Sao Paulo, Brazil
关键词:
D O I:
10.1016/j.ahj/2004.05.047
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Objective To evaluate the efficacy and safety of abciximab following acute myocardial infarction (AMI) treated with, percutaneous coronary interventions. Methods A meta-analysis of randomized controlled trials of platelet glycoprotein IIb/IIIa inhibitor abciximab as adjunctive therapy to percutaneous coronary interventions for AMI was performed. Main outcomes measured were: (i) mortality, (2) reinfarction, (3) target vessel revascularization (TVR), (4) major cardiac events (MACE) that were a composite endpoint of death, reinfarction, and TVR, and (5) major bleeding. Results Six trials randomized 3755 patients who were followed for a mean of 5.5 months. Compared with the control, abciximab significantly reduced mortality (OR 0.70, 95% Cl 0.50-0.97), TVR (0.79, 95% CI 0.65-0.96) and MACE (0.76, 95% Cl 0.65-0.90). Reduction on TVR and MACE was confirmed in stent patients, bug not in balloon angioplasty patients. Abciximab was associated with an increased risk of major bleeding (OR 1.39, 95% CI 1.03-1.87), but bleeding was observed only with a 100U/kg heparin bolus followed by a maintenance infusion (OR 1.89, 95% Cl 1.10-3.28) and not with a bolus of 70U/kg (OR 1.22, 95% Cl 0.85-1.73). Conclusions Abciximab, as adjunctive therapy to percutaneous coronary interventions, reduces mortality, TVR and MACE following AMI. The reduction of clinical outcomes occurs with stent implantation but not with balloon angioplasty 70U/kg heparin bolus must be used to avoid major bleeding.
引用
收藏
页码:937 / 943
页数:7
相关论文
共 25 条
- [1] A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (11) : 1879 - 1885Antoniucci, D论文数: 0 引用数: 0 h-index: 0机构: Careggi Hosp, Div Cardiol, I-50134 Florence, ItalyRodriguez, A论文数: 0 引用数: 0 h-index: 0机构: Careggi Hosp, Div Cardiol, I-50134 Florence, ItalyHempel, A论文数: 0 引用数: 0 h-index: 0机构: Careggi Hosp, Div Cardiol, I-50134 Florence, ItalyValenti, R论文数: 0 引用数: 0 h-index: 0机构: Careggi Hosp, Div Cardiol, I-50134 Florence, ItalyMigliorini, A论文数: 0 引用数: 0 h-index: 0机构: Careggi Hosp, Div Cardiol, I-50134 Florence, ItalyVigo, F论文数: 0 引用数: 0 h-index: 0机构: Careggi Hosp, Div Cardiol, I-50134 Florence, ItalyParodi, G论文数: 0 引用数: 0 h-index: 0机构: Careggi Hosp, Div Cardiol, I-50134 Florence, ItalyFernandez-Pereira, C论文数: 0 引用数: 0 h-index: 0机构: Careggi Hosp, Div Cardiol, I-50134 Florence, ItalyMoschi, G论文数: 0 引用数: 0 h-index: 0机构: Careggi Hosp, Div Cardiol, I-50134 Florence, ItalyBartorelli, A论文数: 0 引用数: 0 h-index: 0机构: Careggi Hosp, Div Cardiol, I-50134 Florence, ItalySantoro, GM论文数: 0 引用数: 0 h-index: 0机构: Careggi Hosp, Div Cardiol, I-50134 Florence, ItalyBolognese, L论文数: 0 引用数: 0 h-index: 0机构: Careggi Hosp, Div Cardiol, I-50134 Florence, ItalyColombo, A论文数: 0 引用数: 0 h-index: 0机构: Careggi Hosp, Div Cardiol, I-50134 Florence, Italy
- [2] Abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantation[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (04) : 353 - 357Antoniucci, D论文数: 0 引用数: 0 h-index: 0机构: Careggi Hosp, Div Cardiol, I-50314 Florence, Italy Careggi Hosp, Div Cardiol, I-50314 Florence, ItalyValenti, R论文数: 0 引用数: 0 h-index: 0机构: Careggi Hosp, Div Cardiol, I-50314 Florence, Italy Careggi Hosp, Div Cardiol, I-50314 Florence, ItalyMigliorini, A论文数: 0 引用数: 0 h-index: 0机构: Careggi Hosp, Div Cardiol, I-50314 Florence, Italy Careggi Hosp, Div Cardiol, I-50314 Florence, ItalyMoschi, G论文数: 0 引用数: 0 h-index: 0机构: Careggi Hosp, Div Cardiol, I-50314 Florence, Italy Careggi Hosp, Div Cardiol, I-50314 Florence, ItalyTrapani, M论文数: 0 引用数: 0 h-index: 0机构: Careggi Hosp, Div Cardiol, I-50314 Florence, Italy Careggi Hosp, Div Cardiol, I-50314 Florence, ItalyDovellini, EV论文数: 0 引用数: 0 h-index: 0机构: Careggi Hosp, Div Cardiol, I-50314 Florence, Italy Careggi Hosp, Div Cardiol, I-50314 Florence, ItalyBolognese, L论文数: 0 引用数: 0 h-index: 0机构: Careggi Hosp, Div Cardiol, I-50314 Florence, Italy Careggi Hosp, Div Cardiol, I-50314 Florence, ItalySantoro, GM论文数: 0 引用数: 0 h-index: 0机构: Careggi Hosp, Div Cardiol, I-50314 Florence, Italy Careggi Hosp, Div Cardiol, I-50314 Florence, Italy
- [3] Mortality and reinfarction reduction with primary stent implantation compared with primary balloon angioplasty[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (09) : 1043 - 1044Araújo, JOQF论文数: 0 引用数: 0 h-index: 0Veloso, HH论文数: 0 引用数: 0 h-index: 0Paiva, JMB论文数: 0 引用数: 0 h-index: 0
- [4] Abciximab in primary coronary angioplasty for acute myocardial infarction improves short- and medium-term outcomes[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (07) : 1996 - 2002Azar, RR论文数: 0 引用数: 0 h-index: 0机构: Hartford Hosp, Div Cardiol, Hartford, CT 06115 USAMcKay, RG论文数: 0 引用数: 0 h-index: 0机构: Hartford Hosp, Div Cardiol, Hartford, CT 06115 USAThompson, PD论文数: 0 引用数: 0 h-index: 0机构: Hartford Hosp, Div Cardiol, Hartford, CT 06115 USAHirst, JA论文数: 0 引用数: 0 h-index: 0机构: Hartford Hosp, Div Cardiol, Hartford, CT 06115 USAMitchell, JF论文数: 0 引用数: 0 h-index: 0机构: Hartford Hosp, Div Cardiol, Hartford, CT 06115 USAFram, DB论文数: 0 引用数: 0 h-index: 0机构: Hartford Hosp, Div Cardiol, Hartford, CT 06115 USAWaters, DD论文数: 0 引用数: 0 h-index: 0机构: Hartford Hosp, Div Cardiol, Hartford, CT 06115 USAKiernan, FJ论文数: 0 引用数: 0 h-index: 0机构: Hartford Hosp, Div Cardiol, Hartford, CT 06115 USA
- [5] Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction[J]. CIRCULATION, 1998, 98 (08) : 734 - 741Brener, SJ论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USABarr, LA论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USABurchenal, JEB论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USAKatz, S论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USAGeorge, BS论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USAJones, AA论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USACohen, ED论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USAGainey, PC论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USAWhite, HJ论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USACheek, HB论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USAMoses, JW论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USAMoliterno, DJ论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USAEffron, MB论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USATopol, EJ论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA
- [6] USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) : 956 - 961CALIFF, RM论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMSHADOFF, N论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMVALETT, N论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMBATES, E论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMGALEANA, A论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMKNOPF, W论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMSHAFTEL, J论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMBENDER, MJ论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMAVERSANO, T论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMRAQUENO, J论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMGURBEL, P论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMCOWFER, J论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMCOHEN, M论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMCROSS, P论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMBITTL, J论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMEDDINGS, K论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMTAYLOR, M论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMDEROSA, K论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMHATTEL, L论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMCOOPER, L论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMESHELMAN, B论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMFINTEL, D论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMNIEMYSKI, P论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMKLEIN, L论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMKENNEDY, H论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMTHORNTON, T论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMKEREIAKES, D论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMMARTIN, L论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMANDERSON, L论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMHIGBY, N论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMELLIS, S论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMBREZINA, K论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMGEORGE, B论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMCHAPEKIS, A论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMSMITH, D论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMANWAR, A论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMGERBER, TL论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMPRITCHARD, GL论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMMYLER, R论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMSHAW, R论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMMURPHY, M论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMWARD, K论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMMADIGAN, NP论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMBLANKENSHIP, J论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMHALBERT, M论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMFLANAGAN, C论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMTANNENBAUM, M论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMPOLICH, M论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMSTEVENSON, C论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NMTCHENG, J论文数: 0 引用数: 0 h-index: 0机构: PRESBYTERIAN HOSP,ALBUQUERQUE,NM
- [7] Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (02) : 132 - 136Chan, AW论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Fdn, Sones Cardiac Catherizat Labs, Sect Intervent Cardiol, Dept Cardiovasc Med, Cleveland, OH 44195 USA Cleveland Clin Fdn, Sones Cardiac Catherizat Labs, Sect Intervent Cardiol, Dept Cardiovasc Med, Cleveland, OH 44195 USAChew, DP论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Fdn, Sones Cardiac Catherizat Labs, Sect Intervent Cardiol, Dept Cardiovasc Med, Cleveland, OH 44195 USA Cleveland Clin Fdn, Sones Cardiac Catherizat Labs, Sect Intervent Cardiol, Dept Cardiovasc Med, Cleveland, OH 44195 USABhatt, DL论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Fdn, Sones Cardiac Catherizat Labs, Sect Intervent Cardiol, Dept Cardiovasc Med, Cleveland, OH 44195 USA Cleveland Clin Fdn, Sones Cardiac Catherizat Labs, Sect Intervent Cardiol, Dept Cardiovasc Med, Cleveland, OH 44195 USAMoliterno, DJ论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Fdn, Sones Cardiac Catherizat Labs, Sect Intervent Cardiol, Dept Cardiovasc Med, Cleveland, OH 44195 USA Cleveland Clin Fdn, Sones Cardiac Catherizat Labs, Sect Intervent Cardiol, Dept Cardiovasc Med, Cleveland, OH 44195 USATopol, EJ论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Fdn, Sones Cardiac Catherizat Labs, Sect Intervent Cardiol, Dept Cardiovasc Med, Cleveland, OH 44195 USA Cleveland Clin Fdn, Sones Cardiac Catherizat Labs, Sect Intervent Cardiol, Dept Cardiovasc Med, Cleveland, OH 44195 USAEllis, SG论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Fdn, Sones Cardiac Catherizat Labs, Sect Intervent Cardiol, Dept Cardiovasc Med, Cleveland, OH 44195 USA Cleveland Clin Fdn, Sones Cardiac Catherizat Labs, Sect Intervent Cardiol, Dept Cardiovasc Med, Cleveland, OH 44195 USA
- [8] Glycoprotein IIb/IIIa inhibition in the setting of acute ST-segment elevation myocardial infarction[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (01) : 1 - 6Eisenberg, MJ论文数: 0 引用数: 0 h-index: 0机构: McGill Univ, Jewish Gen Hosp, Div Cardiol, Montreal, PQ H3T 1E2, CanadaJamal, S论文数: 0 引用数: 0 h-index: 0机构: McGill Univ, Jewish Gen Hosp, Div Cardiol, Montreal, PQ H3T 1E2, Canada
- [9] Relation of stenting to decreased coronary blood flow during primary angioplasty in acute myocardial infarction[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (12) : 1410 - +Escobar, J论文数: 0 引用数: 0 h-index: 0机构: Catholic Univ Chile, Dept Cardiovasc Dis, Santiago, ChileGuarda, E论文数: 0 引用数: 0 h-index: 0机构: Catholic Univ Chile, Dept Cardiovasc Dis, Santiago, ChileMarchant, E论文数: 0 引用数: 0 h-index: 0机构: Catholic Univ Chile, Dept Cardiovasc Dis, Santiago, ChileFajuri, A论文数: 0 引用数: 0 h-index: 0机构: Catholic Univ Chile, Dept Cardiovasc Dis, Santiago, ChileMartínez, A论文数: 0 引用数: 0 h-index: 0机构: Catholic Univ Chile, Dept Cardiovasc Dis, Santiago, ChilePichard, A论文数: 0 引用数: 0 h-index: 0机构: Catholic Univ Chile, Dept Cardiovasc Dis, Santiago, Chile
- [10] Rescue angioplasty in the thrombolysis in myocardial infarction (TIMI) 4 trial[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (01) : 21 - 26Gibson, CM论文数: 0 引用数: 0 h-index: 0机构: HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED, CARDIOVASC DIV, BOSTON, MA 02115 USACannon, CP论文数: 0 引用数: 0 h-index: 0机构: HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED, CARDIOVASC DIV, BOSTON, MA 02115 USAGreene, RM论文数: 0 引用数: 0 h-index: 0机构: HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED, CARDIOVASC DIV, BOSTON, MA 02115 USASequeira, RF论文数: 0 引用数: 0 h-index: 0机构: HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED, CARDIOVASC DIV, BOSTON, MA 02115 USAMargorien, RD论文数: 0 引用数: 0 h-index: 0机构: HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED, CARDIOVASC DIV, BOSTON, MA 02115 USALeya, F论文数: 0 引用数: 0 h-index: 0机构: HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED, CARDIOVASC DIV, BOSTON, MA 02115 USADiver, DJ论文数: 0 引用数: 0 h-index: 0机构: HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED, CARDIOVASC DIV, BOSTON, MA 02115 USABaim, DS论文数: 0 引用数: 0 h-index: 0机构: HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED, CARDIOVASC DIV, BOSTON, MA 02115 USABraunwald, E论文数: 0 引用数: 0 h-index: 0机构: HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED, CARDIOVASC DIV, BOSTON, MA 02115 USA